The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogotá

Background: This study aimed to assess the impact of comorbidities (CMs) on costs, utilities and health-related quality of life (HRQOL) among HIV patients in Colombia. Methods: A cross-sectional study was conducted among 138 HIV patients at an outpatient clinic in Bogotá to assess their costs, utili...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2017
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24045
Acceso en línea:
https://doi.org/10.1080/14737167.2017.1246185
https://repository.urosario.edu.co/handle/10336/24045
Palabra clave:
Colombia
Comorbidity
Cross-sectional study
Family
Human
Human immunodeficiency virus
Major clinical study
Medical record
Model
Multiple regression
Nonhuman
Outpatient department
Quality of life
Statistical significance
Adult
Ambulatory care
Colombia
Comorbidity
Economics
Female
Health care cost
HIV Infections
Male
Middle aged
Pathophysiology
Regression analysis
Adult
Ambulatory Care
Colombia
Comorbidity
Cross-Sectional Studies
Female
Health Care Costs
HIV Infections
Humans
Male
Middle Aged
Quality of Life
Regression Analysis
Acquired Immune Deficiency Syndrome (AIDS)
Bogotá
Burden of disease
Colombia
Health-related quality of life (HRQOL)
Healthcare costs
Human Immunodeficiency Virus (HIV)
Patient and family costs
Utility
Rights
License
Abierto (Texto Completo)
Description
Summary:Background: This study aimed to assess the impact of comorbidities (CMs) on costs, utilities and health-related quality of life (HRQOL) among HIV patients in Colombia. Methods: A cross-sectional study was conducted among 138 HIV patients at an outpatient clinic in Bogotá to assess their costs, utilities (EQ5D-5L) and HRQOL (EQ-VAS). CMs and other covariates were gathered from patient records. Multiple regression models were conducted to assess the impact of CMs. Results: Of all patients, 72% experienced CMs; of these, half experienced ?2 CMs (N = 49). CMs had a statistically significant impact on utilities when the EQ5D-5L (P = 0.022) was applied among patient with ?2 CMs. No statistical significance was found for the impact of CMs on costs. Conclusion: This study suggests that having multiple CMs significantly influences utility, and CMs have some impact on HRQOL measured using the EQ-VAS but this effect is at the border of significance. No significant impact was observed on costs. © 2016 The Author(s). Published by Informa UK Limited, trading as Taylor and Francis Group.